MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,773.95
+0.66%
NASDAQ 100
$31,076.44
+0.87%
DOW JONES
$51,268.00
+0.18%
NASDAQ Composite
$27,477.31
+1.05%
RUSSELL 2000
$2,833.80
+0.66%
CBOE VIX
$15.52
+1.37%
Sector Heatmap
Technology+0.56%
Financials+0.73%
Healthcare+0.72%
Consumer Cycl+0.35%
Consumer Staples+0.63%
Energy+0.99%
Industrials+0.09%
Materials+1.31%
Real Estate-0.34%
Utilities+0.35%
Comm Services+1.17%
INDP — Indaptus Therapeutics, Inc. Common Stock
NasdaqIndaptus Therapeutics, Inc. Common Stock
$2.51
+0.13(+5.46%)
- O
- 2.35
- H
- 2.53
- L
- 2.25
- V
- 356.6K
⏱️ End-of-day dataAs of Oct 5, 2026
INDP — Latest News & Headlines
5 StoriesMRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better - TradingView
MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better TradingView
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in Sep. 2026 - Seeking Alpha
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in Sep. 2026 Seeking Alpha
KOD Stock Cracks September’s Top 5 Biotech Gainers On Eye Drug Win — But ‘Pharma Bro’ Shkreli Says It ‘Still Sucks’ - stocktwits.com
KOD Stock Cracks September’s Top 5 Biotech Gainers On Eye Drug Win — But ‘Pharma Bro’ Shkreli Says It ‘Still Sucks’ stocktwits.com
Indaptus Therapeutics Extends $24 Million Private Placement Closing to Oct. 16 - TradingView
Indaptus Therapeutics Extends $24 Million Private Placement Closing to Oct. 16 TradingView
KOD Stock Cracks September’s Top 5 Biotech Gainers On Eye Drug Win — But ‘Pharma Bro’ Shkreli Says It ‘Still Sucks’ - TradingView
KOD Stock Cracks September’s Top 5 Biotech Gainers On Eye Drug Win — But ‘Pharma Bro’ Shkreli Says It ‘Still Sucks’ TradingView